AIM ImmunoTech amends bylaws to modify stockholder voting and proxy provisions

AIM ImmunoTech Inc. amended its bylaws effective June 9, 2026, modifying Section 1.9 of Article I to clarify voting procedures, proxy rules, and the voting standard for director elections and stockholder proposals. The amendment standardizes voting requirements to a plurality for director elections and majority of votes cast for other proposals, excluding abstentions and broker non-votes.